News Medical

How new approach methodologies and regulation are shaping safer, more predictive therapeutics outcomes

As regulatory authorities accelerate the use of New Approach Methodologies (NAMs), the drug discovery landscape is changing dramatically. This webinar explores how NAMs, immunology-driven platforms, ...
Benzinga.com

DiNABIOS Applauds Historic U.S. Senate Passage of FDA Modernization Act 3.0, Advancing Human‑Relevant New Approach Methodologies (NAMs)

DiNABIOS Applauds Historic U.S. Senate Passage of FDA Modernization Act 3.0, Advancing Human‑Relevant New Approach Methodologies (NAMs) ZURICH/SCHLIEREN, Switzerland, December 24, 2025 – DiNABIOS AG, ...
Morningstar

Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations

Extended projects support ongoing research into computational approaches and new approach methodologies for food and chemical safety assessment Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” ...
Health Affairs

The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 1)

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.